Market News & Trends
Galera Therapeutics Receives FDA Breakthrough Therapy Designation
Galera Therapeutics, Inc. recently announced that the US FDA has granted Breakthrough Therapy designation to lead candidate GC4419, a highly selective and potent small molecule…
Elligo Health Research & Saama Technologies Announce Strategic Partnership
Elligo Health Research is partnering withSaama Technologies, Inc. to improve awareness of, access to, and participation in clinical trials for US physicians and patients. “We…
CicloMed Announces First Patient Dosed With Ciclopirox Prodrug in Phase I Trial
CicloMed LLC recently announced that the first patient has been dosed in a Phase I clinical trial. The CPX-POM-001 study is characterizing the safety, dose…
BC Platforms Launches End-to-End Solution for Precision Medicine Powered by the Microsoft Genomics Service
BC Platforms, a pioneer in genomic data management and analytics, recently announced it has launched GeneVision, a new end-to-end Solution for Precision Medicine, that uses…
Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement With the University of Massachusetts Medical School
Fortress Biotech recently announced that its subsidiary, Aevitas Therapeutics, Inc. (Aevitas), has entered into a sponsored research agreement (SRA) with the laboratory of Guangping Gao,…
PCI Completes Acquisition of Australia-Based Pharmaceutical Packaging Professionals
Leading pharmaceutical outsourcing services provider PCI Pharma Services (PCI) recently announced the completion of its acquisition of Melbourne, Australia-based Pharmaceutical Packaging Professionals (PPP). PPP is…
Vividion Therapeutics Announces Strategic Research Collaboration With Celgene; $101 Million Up-Front Payment
Vividion Therapeutics, Inc., a biotechnology company using revolutionary proteomics and chemistry platforms, recently announced a strategic research collaboration with Celgene Corporation. The multi-year collaboration is focused…
Aduro Announces Development Milestone Achieved Under Merck Collaboration
Aduro Biotech, Inc. recently announced that the company earned a $3-million development milestone payment under its worldwide licensing agreement with Merck (known as MSD outside…
ProJect Pharmaceutics Expands Facilities for Formulation & Lyophilization Process Development
ProJect Pharmaceutics (PJP), specialized in formulation and process development for parenteral drug products, announces that it has extended its safety facilities by laboratories dedicated to…
Fierce Competition Amongst Checkpoint Inhibitor Developers Ahead
Over the next ten years, PD-(L)1 inhibitors will continue to dominate the checkpoint modulators market, says leading data and analytics company GlobalData. PD-(L)1 inhibitors are…
Catalent Completes Multi-Million Expansion at Singapore Clinical Supply Facility
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the completion…
Colorcon Makes Tablets Easier to Swallow
Dysphagia is a common ailment often experienced by the geriatric population. Opadry EZ, Easy Swallow Film Coating System, a new innovative product from Colorcon Inc,…
Soleno Therapeutics Announces Successful End-of-Phase II Meeting With FDA
Soleno Therapeutics, Inc. recently announced the successful completion of and receipt of minutes from its End-of-Phase 2 Meeting with the US FDA concerning Diazoxide Choline…
Fate Therapeutics Announces First Subject Treated with FATE-NK100 in DIMENSION Study for Advanced Solid Tumors
Fate Therapeutics, Inc. recently announced the first subject has been treated in the DIMENSION study of FATE-NK100 for the treatment of advanced solid tumors. The…
Bioluminescent Imaging Capabilities Accelerate Robust CAR T-Cell Therapy
Crown Bioscience recently announced it has enhanced its existing platform for chimeric antigen receptor (CAR) T-cell agent evaluation with bioluminescent imaging capabilities. CAR T-cell therapies…
Sernova’s Clinical Trial Supported With Continuous Glucose Monitoring Systems
Sernova Corp. recently announced continuous glucose monitoring systems [CGM (Medtronic Minimed, Northridge, CA)] will be provided to patients in Sernova’s US regenerative medicine clinical trial…
Amunix Announces Licensing Agreement With Celgene
Amunix Operating Inc. recently announced it has entered into a licensing agreement with Celgene. The agreement allows for the utilization of Amunix’s proprietary XTEN and…
Novo Nordisk Successfully Completes Phase 3a Trial Using Emisphere's Technology
Novo Nordisk recently announced the successful completion of the first Phase 3a trial, PIONEER 1, with oral semaglutide, a once-daily oral formulation of the long-acting…
Biohaven Announces Exclusive License Agreement With Catalent
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company") recently announced it has entered into an exclusive worldwide license agreement with Catalent U.K.…
Lonza Expands Encapsulation & HPAPI Capabilities in North America
Lonza recently announced the expansion of its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company…
